Cipla Q1FY27 Investor Presentation - Highest-ever Revenue

Order Pipeline DisclosedInvestor Communications View source PDF

CIPLA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-0.5%1-day move

₹1415.90

prior close

₹1377.30

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.2+0.6+0.7-0.4-0.5-0.1+2.1———————

Up moveDown movePending

AI summary

Cipla shared its Q1FY27 investor presentation. Revenue hit a record INR 7,119 Cr, up 12% YoY. However, EBITDA fell to INR 1,192 Cr (margin 16.7% versus 25.6% YoY) and PAT dropped to INR 789 Cr. One India contributed 48% of revenue. Launched gVentolin in the US. Pipeline: 186 approved ANDAs, 48 under approval.

Likely market impact

Record revenue is positive but sharp margin compression in Q1 may concern investors despite India growth and US product launches.